FibroGen CFO, Chief Medical Officer to leave
PremiumThe FlyFibroGen CFO, Chief Medical Officer to leave
2M ago
FibroGen reports Q2 EPS (16c), consensus (32c)
Premium
The Fly
FibroGen reports Q2 EPS (16c), consensus (32c)
3M ago
FibroGen options imply 25.4% move in share price post-earnings
Premium
The Fly
FibroGen options imply 25.4% move in share price post-earnings
3M ago
FibroGen trading halted, news pending
PremiumThe FlyFibroGen trading halted, news pending
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Truist biotech analyst holds an analyst/industry conference call
Premium
The Fly
Truist biotech analyst holds an analyst/industry conference call
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
FDA clears FibroGen’s IND application of FG-3165 for solid tumor treatment
Premium
The Fly
FDA clears FibroGen’s IND application of FG-3165 for solid tumor treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100